Pangea Bio
Transformative medicines inspired by nature's neuroactive chemistry
London, United Kingdom · Founded 2021
- Headquarters
- London
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- pangeabio.com
About
Pangea Bio is a UK-based clinical-stage biotechnology company developing transformative medicines for neurological and mental health disorders. The company uses AI to unlock nature's neuroactive chemistry, identifying and optimizing naturally occurring compounds to create novel small molecule therapeutics. Pangea's lead program focuses on next-generation TrkB receptor activators that drive neuronal and synaptic plasticity, targeting conditions including schizophrenia, depression, and Alzheimer's disease. In December 2025, Pangea received Clinical Trial Authorization from the UK MHRA for its lead candidate OT-003, marking its transition to a clinical-stage company.
Summary
Pangea Bio is a Biotech company based in London, United Kingdom, founded in 2021.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/pangea-bio"><img src="https://indexed.vc/api/badge/company/pangea-bio" alt="Pangea Bio on Indexed.vc" width="260" height="76" /></a>